FM
HZNP

Family Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Family Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,000
Closed -$131K – 76
2017
Q2 		$131K Buy
+11,000
New +$137K 0.09% 62

Other funds holding HZNP

SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Family Management's HZNP Position: Q3 2017 in Review

Family Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2017, closing a stake of 11,000 shares — an estimated $131K sold.

Family Management first reported a position in HZNP in Q2 2017 and held it in 1 quarter. The position peaked at $131K in Q2 2017. 181 funds tracked by Wall St. Rank hold HZNP as of Q3 2017.

  • Family Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2017 after selling out during the quarter.
  • Family Management sold 11,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2017, an estimated $131K.
  • Family Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2017 and held it in 1 quarter.
  • Family Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $131K in Q2 2017.
  • 181 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2017.

Based on Family Management's 13F filing for Q3 2017, filed 13 Nov 2017.